Movement Alert|Hims & Hers Health Inc. Falls 5.09% in Pre-Market Trading, Q3 Miss and Expanded FTC Lawsuit Continue to Weigh

Market Focus11-12

On November 12, Hims & Hers Health Inc. fell 5.09% in Pre-Market Trading, trading at $19.78 per share, with turnover of $1.6272 million.

The move followed continued pressure from the company’s weaker-than-expected third-quarter results, soft fourth-quarter and full-year revenue outlook, and an expanded FTC lawsuit that added five states as co-plaintiffs.

Hims & Hers Health Inc. reported a Q3 loss of $0.14 per share versus market expectations for a $0.06 profit, while revenue rose to $890.4 million but missed consensus near $893 million. The company guided Q4 revenue to $875 million-$895 million, below expectations of about $953.8 million, and now expects full-year revenue of $3.13 billion-$3.15 billion versus consensus near $3.21 billion. Separately, the amended FTC complaint alleges improper privacy, billing, and subscription-cancellation practices, increasing near-term uncertainty after this week’s sharp post-earnings selloff and partial rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment